Waters Corp (WAT) has seen multiple quarters of
strong performance, beating sales expectations and consistently raising guidance. Their
lab equipment is in high demand, driving up annual profit forecasts. They have also launched innovative technologies like
Charge Detection Mass Spectrometry, highlighting their role in accelerating the development of biotherapeutics. Despite some ups and downs in its stock performance, the general consensus is that Waters Corp is a strong long-term growth stock. They have also achieved an 80-plus
Relative Strength Rating. News has also centered around their
industry partnerships and acquisitions such as combining with BD's Biosciences & Diagnostic Solutions business and acquiring Halo Labs thereby diversifying their portfolio. Some speculate that the company's strong financials may temporarily offset stock weaknesses. Their business in India has seen a boost due to a surge in demand for weight-loss drugs. Discussions on
future growth, visible in an optimistic sales guidance and executives' discussions of goals for 2025 suggest a healthy outlook for the company.
Waters Corp WAT News Analytics from Wed, 12 Feb 2025 08:00:00 GMT to Sat, 22 Nov 2025 21:56:04 GMT -
Rating 8
- Innovation 7
- Information 8
- Rumor -6
